Track topics on Twitter Track topics that are important to you
De Van Leeuwen Buizen Groep profiteerde in 2017 van een aantrekkende marktvraag in Europa, hogere prijsniveaus wereldwijd en kostenmaatregelen genomen in voorgaande jaren.Omzet Read more...
In this episode of PharmaTelevision News Review, filmed at BioPharm America in Boston, Fintan Walton talks to David de Graaf, CEO of Selventa
ING Groep NV lowered its position in Bristol-Myers Squibb Co by 15.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 234,349 shares of...
David de Graaf, Ph.D., has stepped down from his position as CEO and resigned from the company’s Board of Directors.
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on GNW, ING, PFG, and PRU which can Read more...
Jean-Paul Kress has been appointed president and CEO of Syntimmune. Kress will also serve as a director of the New York-based drug developer. He replaces David de Graaf, who has stepped down as CEO an...
We have published hundreds of Reinier de Graaf Groep news stories on BioPortfolio along with dozens of Reinier de Graaf Groep Clinical Trials and PubMed Articles about Reinier de Graaf Groep for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Reinier de Graaf Groep Companies in our database. You can also find out about relevant Reinier de Graaf Groep Drugs and Medications on this site too.